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Abstract
Nanoscale size and fiber like structure of carbon nanotubes (CNTs) may determine high reactivity 
and penetration, as well as the pathogenicity of asbestos and other mineral fibers. Despite many in 
vitro and in vivo studies, the absence of full-scale data on CNT effects on human health clearly 
point out the necessity for epidemiological studies. Currently, several projects are initiated 
worldwide on studying health risks associated with the inhalation of industrial CNTs, including 
NIOSH-promoted research (United States), the European CANTES study, and the Russian CNT-
ERA project. Studies comprising several successive steps, such as CNT exposure assessment in 
occupational settings, toxicological evaluation, and epidemiological observations, are critical for 
determining material safety and use criteria.
INTRODUCTION
According to the EU definition of 2011 [1], carbon nanotubes (CNTs) are classified as 
nanomaterials. At the same time, based on the morphological parameters (length and aspect 
ratio), CNTs behave as fibers [73]. This dual nature of carbon nanotubes may determine 
their high reactivity and penetration [61], as well as the pathogenicity similar to asbestos and 
other mineral fibers [30]. CNT production is growing every year [4] due to their application 
in construction [97], machine engineering [17], electronics [15], power industry [19], space 
engineering [5], and biomedicine [75, 93]. Therefore, both specialists and consumers 
question the safety of CNT, as well as technological processes associated with CNT 
production and application. It would be rather unwise to assume that the innovative branch 
of nanoindustry is environmentally friendly. Failure to take action may slow down 
development and lead to financial losses of industrial enterprises. In particular, getting such 
products to the market without safety guarantees may damage the reputation and public 
image of a company, as well as cut off access to new markets. In addition, these innovative 
enterprises require assistance in solving such problems as registering new chemicals, 
product certification, the organization of a labor-protection system, and medical supervision 
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risks, as well as working out approaches to increase the efficiency of risk management, are 
very important for the sustainable development of this industrial branch [9].
EARLY HYPOTHESES AND FIRST EVIDENCE OF CNT TOXICITY
The toxic effects of CNTs have been studied since the early 2000s, when they were 
produced only in laboratories and during experimental manufacturing. Toxicological 
experiments were aimed at detecting susceptible organs and systems. Inhalation and dermal 
penetration were viewed as the main pathways CNTs could enter the human body [23, 55]. 
The design of experiments was based on such hypotheses of the interaction between 
nanoparticles and biological objects as oxidative stress and mechanical damage to cell 
structures. The first in vivo studies were performed on the toxicity of single-walled carbon 
nanotubes (SWCNTs) [44, 47, 50, 84, 91, 94]; but in a few years the focus shifted to 
multiwalled CNTs (MWCNTs) [32, 49, 57, 70, 88], because the latter were more 
commercially attractive.
In the experiment on mice [44], SWCNTs, carbon black (negative control), and quartz 
(positive control) were compared. In mice intratracheally instilled with 0.1–0.5 mg of 
nanotubes, the number of granulomas in the lungs was greater, and the inflammatory 
response was significantly stronger than those treated with quartz and carbon black. In [94], 
the pilot investigation was aimed at comparing the pulmonary effects produced by 
SWCNTs, quartz particles, and carbonyl iron particles in rats intratracheally instilled with 
1–5 mg/kg of the corresponding substance. Exposures to SWCNTs produced transient 
inflammation and tissue damage, as well as non-dose-dependent series of nonprogressive 
multifocal granulomas. The researchers came to the conclusion that these granulomas were 
evidence of a foreigh-object body reaction. In the aspiration experiment [84] (pharyngeal 
aspiration as a model of inhalation) on mice treated with SWCNTs at doses of 10, 20, 30, 
and 40 μg/mouse, a dose-dependent inflammation and fibrosis accompanied with alveolar 
wall thickening was found. At the same time, the materials taken for comparison (nanosized 
carbon black and silicon dioxide) did not cause alveolar wall thickening or granulomas. The 
inflammatory response was significantly weaker than at the same exposure doses. When 
comparing SWCNTs, carbon black, and vanadium oxide (pharyngeal aspiration, 2 mg/kg), it 
was found [47] that SWCNTs caused interstitial fibrosis, a significant increase in mRNA 
expression responsible for the platelet-derived growth factor, and the formation of carbon 
structures that bridge alveolar macrophages in situ. It could depend, according to 
researchers, results from the unique morphology of nanotubes and/or the presence of 
residues of metal catalysts. The bridges between macrophages were regarded as biomarkers 
of exposure. The important role of dispersion degree during exposure was shown in [50]. 
Researchers revealed that exposure to highly dispersed SWCNTs (pharyngeal aspiration, 10 
μg/mouse) caused only interstitial fibrosis, whereas material with a low dispersion degree 
was characterized by fibrosis and granulomas.
In 2008, Takagi et al. [88] suggested using peritoneum as a pleura model. p53 +/− 
heterozygous mice (with a genetically inherited high risk of tumors) were administered 
intraperitoneally with 3 mg of MWCNTs or asbestos (crocidolite). In both cases, 
mesothelioma was induced, but the experiment was criticized by the scientific community 
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because the dose was too high [24]. In the same year, Poland et al. [68] performed a similar 
comparative study of MWCNTs, asbestos, and ultrafine carbon black. The particles were 
injected into mice intraperitoneally at a dose of 50 μg (as opposed to 3 mg in [88]). Both 
asbestos and MWCNTs caused significant protein exudation and the formation of 
granulomas with cell aggregates. The researchers concluded that asbestos-like pathogenicity, 
which is assigned to CNTs, is achieved by the mechanism of the structure-activity 
relationship peculiar to asbestos and other fibrogenic fibers. In later experiments, the CNT 
translocation of the respiratory tract into the interstitium, subpleural space, and pleura was 
demonstrated [50, 70, 74]. Another feature of CNTs was their high biopersistence, i.e., a 
long period of stay in the pulmonary system as a result of inhalation or aspiration [13].
In vivo experiments on evaluating dermal toxicity have not been performed. However, the in 
vitro experiments of Monteiro–Riviere et al., revealed that MWNTs can penetrate into 
keratinocytes and stimulate an immune response, in particular IL-8 extraction [55, 83], as 
well as the high activity of free-radical oxidation and structural changes in keratinocytes 
(HaCaT culture) exposed to SWCNTs, which suggested the presence of dermal toxicity in 
the studied nanotubes.
The in vitro experiments were aimed at establishing the damaging effects of nanoparticles. 
In the first place, researchers were interested in oxidative stress and associated cyto- and 
genotoxic effects, the mechanical effect of nanotubes on cellular structures, and specific and 
nonspecific interactions with the receptors. Srivastava et al. 2010 [86] found oxidative stress 
and apoptosis in A549 cells (alveolar epithelium) exposed to MWCNTs, and the production 
of reactive oxygen species occurred, as was suggested by the researchers, via the 
cytochrome P450 system. Previously [78] the same mechanism of oxidative stress was 
shown in the cell culture of alveolar epithelium in response to SWCNTs. When studying the 
genotoxic effects of exposure to CNTs on RAW of 264.7 macrophages, the researchers 
detected some signs of damage to the genetic apparatus of cells at concentrations above 0.1 
mg/mL for SWNTs and above 1 mg/mL for MWCNTs, although the cytotoxic effects 
appeared only at the highest doses (100 mg/mL) [53]. The toxicogenomic comparison of 
asbestos and MWCNTs in the experiment on human bronchial epithelial cells revealed 
changes in the expression of 12 common genes associated with mesothelioma and 22 
common genes associated with lung cancer [42]. In studies [36, 37, 71, 80] it was found that 
MWNTs may associate with the cell membrane, including bronchial epithelial and 
macrophages, and disrupt its integrity, inducing the development of proinflammatory 
cytokines and cell death.
Therefore, oxidative stress and cytotoxic effects of CNTs have been shown for keratinocytes 
(see above), epithelial cells, and macrophages [17, 34, 36, 37, 71, 78, 80, 86]. Genotoxic 
effects and tumor induction were also observed [29, 41, 53, 76]. CNT interaction with 
specific receptors at the surface of cell membranes and/or organelles has not been identified, 
which may be due to the lack of any recognizable domains in nanotubes. It is most likely 
that there is no common toxic effect of CNTs, which would explain all of the observed 
effects. Further research is needed, including the application of modern cell and molecular 
techniques.
Fatkhutdinova et al. Page 3













During this period, the first hygienic assessments of exposure to CNTs in the workplace 
were performed simultaneously with the toxicological experiments. They were based on 
indirect methods for determining impurities (catalysts such as nickel or cobalt) in the 
working area [14, 40, 48]. The results of measurements in conjunction with the data on 
electron microscopy of the samples demonstrated that the staff can contact CNTs.
It is noteworthy that the general restrictions for the initial phase of research were high 
exposure doses calculated for the easily registered biological response, the use of laboratory 
purified and/or modified samples rather than industrial CNTs, the poor relation of the 
exposure model in in vivo and in vitro experiments with real working conditions, and a lack 
of data on the actual exposure in the environment.
EVALUATION OF CNT TOXICITY IN THE CURRENT PERIOD
The later period of studies on CNT toxicity is characterized by some innovations. Complex 
inhalational units for CNT aerosolization with constant control over the number and size of 
individual particles were developed. Thus, it became possible to lauch chronic experiments 
for 1 year or more using low doses during the inhalation [51, 85] and confirm the specific 
profibrogenic effects of CNTs established during the acute and subacute experiments. In 
addition, the researchers began to pay more attention to extrapulmonary effects: systemic 
affection of the vascular bed [25], effects on the central nervous system [39], reproductive 
toxicity [3], and changes in the immune status [54]. It was proven that CNTs can induce 
neoplastic processes [28, 77, 82] and an allergic response [38, 64, 66]. In November 2014, 
the International Agency for Research on Cancer (IARC) classified MWCNT-7 (produced 
by the Mitsui ltd., Japan) as Group 2B: possibly carcinogenic to humans [31].
Significant changes took place in the hygienic evaluation of CNTs. The indirect methods for 
determining the content of CNTs in the environment (based on catalyst residues) were 
replaced by the direct calculation of elemental inorganic carbon, a component of carbon 
nanotubes [18, 52].
Toxicological experiments and the development of hygienic methods of research in the 
nanoindustry ensured the transition to the stage of epidemiological studies.
Currently, data on the effect of CNTs on the health of exposed individuals are insufficient, 
but there are several documented cases of CNT detection in the body of people affected due 
to a variety of reasons.
In particular, after the tragedy of 2001 in New York, a large number of rescue workers and 
persons providing assistance with debris removal and victim extrication had their pulmonary 
system affected by combustion products of building materials, fuel, and other substances 
[96]. High combustion temperatures contributed to the formation of tubular carbon 
nanostructures that were very similar to artificial CNTs. Subsequently, 12 891 people were 
examined during the screening program. Many of them had symptoms of respiratory lesions. 
In seven of the most severe cases, lifetime lung biopsy was performed. Four patients had 
CNTs, along with other dust particles in their bioptates, which were similar to carbon 
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nanostructures found in dust samples at the crash site; they had such pathological changes 
such as cellular fibrosis, chronic bronchiolitis, and granulomas [35].
German researchers described a case of toner nanoparticles found in the peritoneum when 
screening the peritoneal cavity of a female office worker with complaints about persistant 
abdominal pain [90].
The studies of suspended particles in the air are of particular interest. During a long-term 
epidemiological cohort study performed in the 1990s on the basis of six cities in the United 
States, it has been shown that mortality from all causes, as well as cardiovascular and 
cardiorespiratory mortality, was significantly dependent on the content of dust in the air of 
cities [22]. More recent studies have confirmed the role of fine (PM2.5, PM5, PM10) [69] as 
well as ultrafine (less than 1 μm) atmospheric particles in mortality from cardiovascular and 
pulmonary disease [16, 87, 95]. The accumulated experience of studying the effects of 
suspended particles in air on human health proves the need for field studies, including an 
assessment of exposure and the study of human health affected by nanoparticles.
In Taiwan, the first epidemiological study in the nanoindustry was performed in 2009–2010. 
It was based on 13 companies that produce or use nanoparticles of various types, including 
nanosized metals and their compounds, carbon nanoparticles (fullerenes, CNTs, and 
nanosized carbon black), and organic nanosized structures (dendrimers, liposome, etc.) [45]. 
During the study, the markers of cardiovascular and respiratory systems lesions, 
neurological functions, and immune-system state were evaluated. The results showed a 
decrease in the total antioxidant protection, an increase in the content of cardiovascular 
markers (C-reactive protein, and VCAM protein), and changes in heart-rate variability and 
cognitive functions. In the cross-sectional part of the study, functional changes in the 
respiratory system were not revealed, but there were signs of a decline in the respiratory 
functions during the prospective observation. The study was restricted by the absence of 
workers’ subdivision according to specific types of nanoparticles.
Complex projects that combine a sequential assessment of CNT content in the environment, 
toxicological studies, and epidemiological observations are the most promising in terms of 
studying the effect of CNTs on health. Epidemiological studies involving the collection of 
biological samples in a relatively small population (for example, people working in 
enterprises that produce and apply CNTs) should be carefully prepared. First, it is necessary 
to determine potential outcomes and biological markers of exposure to nanoparticles. In this 
case, toxicological experiment most closely matching the real exposure scenario is preferred, 
including the application of the same nanoparticles which are found in the environment at 
doses corresponding to the actual concentration along with the same ways of penetration. 
However, organizing this type of research is associated with numerous challenges, including 
the need to establish multidisciplinary teams, the development of methodological 
approaches for the transition from the CNT concentration in the external environment to the 
doses accumulated in the body, the selection of biomarkers of exposure and effect, and the 
relatively small (as of today) group of exposed persons as well as the difficult access to 
objects of the nanoindustry.
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According to an international group of experts [72], the studies on toxicokinetics/
toxicodynamics and noncarcinogenic effects of inhaled CNTs during the synthesis, 
processing, use, and disposal of the material should be considered the most important. At 
present, several projects on studying health risks associated with the inhalation of industrial 
CNTs are implemented: NIOSH-promoted research (United States), the Dutch CANTES 
study, and the joint Russian–United States CNT-ERA project.
In 2013, the launch of a small-format (about 100 employees) cross-sectional study to 
identify the relationship between exposure to carbon nanotubes and nanofibers and early 
changes in the pulmonary and cardiovascular systems was reported in the United States [27]. 
Currently, exposure in the workplaces is assessed in various ways to determine the relevant 
criteria for determining the content of CNTs and carbon nanofibers (CNFs) in the working 
environment [18, 26].
The study will include employees of at least ten enterprises producing and using various 
CNTs and CNFs. It is expected that the samples of blood and induced sputum will be taken 
from people under study. The selection of biological markers and survey methods was based 
on in vivo and in vitro toxicity studies of CNTs and CNFs; data from research on the 
pathophysiology of the tumor, fibrotic and inflammatory processes; and the results of studies 
of the medical and biological effects of non-carbon nanoparticles in humans [33, 45].
In 2014, the staff of several scientific institutions in the Netherlands and Belgium launched a 
study on early biomarkers of individual exposure to CNTs with a simultaneous hygienic 
assessment of the content of nanoparticles in the workplace air (CANTES). During the 
study, the content of elemental carbon in the air of an enterprise producing CNTs was 
assessed. Samples of blood, urine, and nasal and buccal epithelial cells were taken from the 
staff of the enterprise to assess a number of biochemical parameters and cytokine status. The 
results of the study have not yet been published in the form of articles, but the researchers 
reported increased levels of proinflammatory cytokines in the study group compared to the 
controls [92].
PROTOCOL OF THE RUSSIAN (CNT-ERA) STUDY ON CARBON NANOTUBES EXPOSURE 
AND RISK ASSESSMENT
Our study, which was started in 2011, includes hygienic, toxicological, and epidemiological 
stages.
At the initial stage of the study, we selected enterprises using the same type of reactors for 
the production of MWCNTs and performed a hygienic evaluation of the working places 
while determining the actual 8-hour TWA concentrations. Air sampling in the filters was 
carried out in the areas of contact with the aerosol MWCNTs followed by transmission 
electron microscopy to visualize nanotubes in the samples and determine the amount of 
elemental carbon by thermo-optical analysis.
Before planning the panel epidemiological study, a series of toxicological experiments [10, 
11, 12] was performed during which the promising biomarkers of the effect were 
determined. The biological effects of industrial CNTs were studied in mice, cell cultures of 
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macrophages, and cells of the bronchial epithelium. The exposure doses were selected based 
on the measured concentrations of MWCNTs in the air of the working environment, 
followed by the calculations of the deposited fraction in human lungs (according to the 
MPPD model [21]) and the accumulated deposited surface area doses (per 1 cm2 of the 
alveolar epithelium). The exposure doses were determined based on the accumulated 
deposited surface area doses, taking into account the surface area of the alveolar epithelium 
in mice. Promising markers of profibrotic changes were selected, such as TGF-b and 
osteopontin (osteopoetin), which were later included in the scheme of epidemiological study 
CNT-ERA. In addition, based on the interstitium affection identified during the in vivo 
experiments, the biomarker panel was supplemented by Krebs von den Lungen-6 (KL-6) 
factor, a mucinlike high molecular weight glycoprotein, marking various interstitial lung 
diseases in humans [43, 89].
In 2014, Erdeli et al. [26] presented the results of inhalation studies in mice in which the 
calculation of the exposure doses was also based on the concentration of MWCNTs 
measured in the air of a number of enterprises. However, in contrast to our study, the US 
group studied enterprises producing and applying different types of MWCNTs. Thus, it was 
decided that the toxicological experiment would be based not on MWCNTs provided by the 
enterprises participating in the study, but rather the purified commercial sample purchased 
from the company. In addition, the researchers did not set out a specific task for selecting 
biomarkers, thereby being restricted to comparing the effects of different doses in relation to 
nonspecific indicators of local (in the lung tissue) inflammation.
At the present moment, at the Russian enterprises participating in the study is carrying out a 
panel investigation with the sampling of blood, nasal lavage, and induced sputum from the 
workers and a control group for further evaluating the content of fibrosis markers and 
systemic vascular effects. During the panel study, the biological samples from the same 
person are taken repeatedly. The advantage of this approach is that each participant is their 
own control. In case of high-precision methods, such a panel study provides qualitative and 
quantitative assessments of health risks even for a small number of participants [65, 79].
The successful completion of panel studies will allow us to organize a smooth transition to 
large-scale epidemiological projects. At the same time, it is necessary to consider the 
possibility of an international consortium to develop a single protocol of prospective study 
with the standardization of approaches to sampling, assessing industrial exposures, the 
selection of biological samples, and functional study methods. Applying the methods used in 
genomics, proteomics, and lipidomics will make it possible to identify specific changes in 
animals and humans that are not masked by nonspecific reactions.
An important component of the system for studying the risk of exposure to carbon 
nanotubes is the development of banks with biological samples taken from the workers in 
the course of observation with the possibility of delayed analysis as new hypotheses will 
appear.
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MEETING THE CHALLENGES OF HYGIENIC STANDARDIZATION
In order to proceed to the assessment of risk in the workplaces and in the environment, we 
need data on acceptable levels of exposure to CNTs, but their development has been facing 
various difficulties, including the variety of CNT types, the complexity of their 
identification and quantitative evaluation in the environment, inadequate methodological 
approaches, and insufficient data on their biological effects.
One way to determine approximate safe exposure levels (ASELs) is to extrapolate the results 
of animal experiments based on the use of the lowest observed adverse effect levels with the 
application of risk-assessment methodology and establishment of the uncertainty factor. The 
first attempts to establish safe exposure levels (for MWNTs) were based on the results of 
subchronic inhalation experiments. The Nanocyl Company (Belgium), having assessed the 
risk and obtained an uncertainty factor of 40 based on the lowest observed adverse effect 
concentrations set out by Ma-Hock et al. [60] in the subchronic (90 days) inhalation 
experiments on rats [46], determined the no effect 8-hour weighted concentration for its 
MWCNTs (2.5 μg/m3). Aschberger et al. [13] suggested the ASEL of 1 μg/m3 for MWNTs 
taken by Ma-Hock [46], and 2 μg/m3 for the Baytubes (Bayer MaterialScience, Germany) 
used by Pauluhn et al. [67] in a 13-week experiment based on the uncertainty factors of 50 
and 25, respectively (obtained after the recalculation of the threshold levels of exposure and 
external respiration in rats and humans).
The Japanese National Institute of Advanced Industrial Science and Technology established 
the acceptable exposure level of 30 μg/m3 for all types of CNTs [58, 59]. The ratio was set 
for a period of 15 years as a result of the inhalation experiment with MWCNTs (Nikkiso 
Co., ltd) in rats performed by Morimoto et al. with both SWCNTs and MWCNTs [56].
In 2010, the National Institute for Occupational Safety and Health (NIOSH, United States), 
having performed a quantitative risk assessment on the basis of the previous in vivo studies 
[44, 46, 67, 70, 81], found that the mean CNT concentration during the working shift (0.2–2 
μg/m3) upon exposure during the working time is associated with a 10% risk of respiratory 
diseases. However, taking into consideration the inadequate techniques for the detection and 
calculation of CNTs in the samples, the suggested recommended exposure level (REL) was 
7 μg/m3 (calculated as elemental carbon determined using the method of thermo-optic 
analysis) [62]. In April 2013, a new report was published by NIOSH which established the 
recommended exposure level for all types of CNTs of 1 μg/m3. This was associated with an 
increase in the accuracy of procedures and, therefore, lower detection limits of CNTs in the 
samples [63].
In 2010, the Russian Federal Service for Supervision of Consumer Rights Protection and 
Human Welfare set out the ASELs for three nanomaterials, including SWNTs [2]. The 
drafters of the document were guided by the maximum allowable level of 0.01 fibers/m3, 
which was suggested by the British Standards Institution in 2007, calculated as 1/10 of the 
maximum allowable level for asbestos fibers. Simultaneously, in 2010, the Russian Federal 
Service for Supervision of Consumer Rights Protection and Human Welfare published 
several methodic recommendations on a quantitative determination of nanomaterials, 
including carbon nanotubes [6, 7]. According to these documents, it is suggested to detect, 
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identify, and calculate the number of CNT particles by transmission electron microscopy 
with contrasting by the salts of heavy metals. Infrared photoluminescence spectroscopy and 
infrared absorption spectroscopy can be used as additional methods of identification 
methods. It is suggested to take air samples using Krotov's apparatus with the deposition of 
aerosol particles in water. It should be noted that the opened Russian literature offers no data 
on the content of CNTs in air of the working place obtained using the methodology 
described above. Our results show that this approach does not allow an objective assessment 
of CNT content in the air, because it is extremely difficult to calculate individual nanotubes 
in the selected samples due to the rapid agglomeration of the particles.
Therefore, the recommended exposure levels for different CNTs in the world vary from 1 to 
50 μg/m3 (for 8-hour TWA concentrations). For comparison, the short-term exposure limit 
of carbon black in Russia is 4 mg/m3; the 8-hour TWA concentration of carbon composite 
materials is 1 mg/m3 [8]. Unfortunately, Russian experts have to rely on these values, for 
example, during toxicological evaluation of products.
CONCLUSIONS
1. In vivo and in vitro toxicological experiments allowed the presence of pronounced 
local profibrogenic effects produced by CNTs to be established on lung tissue. In 
addition, recent data suggest the potential possibility of extrapulmonary effects, 
such as systemic vascular changes and the affection of the immune status.
2. Under the conditions of insufficient data on the biomedical effects of CNTs, as well 
as the absence of reliable safety criteria for humans, it is urgent for assessing health 
risk to perform studies in exposed groups of people. Despite the small (at the 
current stage) number of exposed persons, a panel study with investigation of both 
local and systemic responses to CNT inhalation is the most favorable. Promising 
biomarkers are those of fibrosis and lesions of the cardiovascular system, as well as 
cytokines responsible for the development of inflammation and allergic reaction. 
This list will be enlarged with respect to in vivo and in vitro experiments. Thus, it 
is important to create a bank of biological samples (blood, urine, induced sputum, 
and buccal cells) to test new promising indicators.
3. Epidemiological studies should be carefully prepared. Complex projects combining 
a sequential assessment of CNT content in the environment, toxicological studies, 
and epidemiological observations are the most promising.
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